Abstract:Objectives: The objectives were to examine the correlation between soluble Fas (sFas) level and apoptosis of T cells in peripheral blood and peritoneal fluid of patients with ovarian carcinoma and to investigate the possible sFas effect on T cell apoptosis.Study design: Patients with stages I-II ovarian carcinoma (n = 10) and patients with stages III-IV ovarian carcinoma (n = 22), as well as ovarian benign tumors (n = 8), were enrolled in the study. Apoptosis of and Fas expression on T cells from peripheral blood and peritoneal fluids were assessed by flow cytometry. Soluble Fas level was assayed using an ELISA kit. The effects of peritoneal fluid on Jurkat cell apoptosis with or without depletion of sFas were evaluated and compared in vitro.Results: The sFas level and apoptosis of T cells in peripheral blood and peritoneal fluid from stages III-IV ovarian carcinoma were significantly higher than those from stages I-II ovarian carcinoma (p < 0.01 in all instances) and benign ovarian tumor (p < 0.01 in all instances). In peritoneal fluid, the sFas level and apoptosis of T cells from stages I-II ovarian carcinoma were significantly higher than those from benign ovarian tumor (p < 0.01 in all instances), and the Fas expression on T cells from ovarian carcinoma were higher than those from benign ovarian tumor (p < 0.05 in all instances). There was a positive correlation between the sFas level and the apoptosis of T cells in peritoneal fluids from stages III-IV ovarian carcinoma (r = 0.647, p = 0.001). Peritoneal fluid of ovarian carcinoma could induce significant Jurkat cell apoptosis. The blocking of Fas expression on the Jurkat cell surface, but not the deletion of sFas, may remarkably restrain the apoptosis level.Conclusions: Elevated sFas is correlated with apoptosis of T cells in peripheral blood and peritoneal fluid from ovarian carcinoma. Soluble Fas evidently does not affect T cell apoptosis, which is probably due to elevated Fas expression on T cells. (C) 2007 Elsevier Ireland Ltd. All rights reserved.

[Interferon-gamma up-regulates Fas expression and increases Fas-mediated apoptosis in tumor cell lines].

IFN-γ Regulates Fas/FasL Expression in Cholangio Carcinoma Cells

Study on the Signal Transduction in Apoptosis of L929 Cell Induced by IFNγ-LTα and LTα

[Up-Regulation of Fas is Related to Apoptosis of HeLa Cells Induced by Co-Immobilized TNF-alpha/IFN-gamma].

Analysis of Fas and Fas Ligand expression and function in lung cancer cell lines

Effect of Up-expression of Fas Ligand on the Apoptosis of Gastric Carcinoma

Blockade of Fas Signaling in Breast Cancer Cells Suppresses Tumor Growth and Metastasis Via Disruption of Fas Signaling-initiated Cancer-related Inflammation*

Over-expressed Fas Improves the Apoptosis of Malignant T-cells in Vitro and Vivo.

Induction of Apoptosis in Glioma Cells and Upregulation of Fas Expression Using the Human Interferon-Β Gene.

[Detection of Cell Apoptosis Induced with Anti-Fas Antibody in Bladder Carcinoma Cell Line by Single Cell Gel Electrophoresis].

[Apoptosis of Lymphocytes Induced by Fas/FasL of Colon Cancer Cells].

Induction of tumor cell apoptosis via Fas/DR5.

The Up-Regulation of the Expresion of Fas Gene by Adriamycin on Tumor Cells

The effect of Fas/FasL's expression in hepatocellular carcinoma with HBV infection

Correlation Between Soluble Fas Level and Apoptosis of T Cells in Ovarian Carcinoma.

Fas Ligand Expression in Colon Cancer: A Possible Mechanism of Tumor Immune Privilege

Cross-talk between tumor cells and neutrophils through the Fas (APO-1, CD95)/FasL system: human glioma cells enhance cell viability and stimulate cytokine production in neutrophils

Effect of Selenium on the Expression of Fas/FasL in T Lymphocyte Anti Colonic Cancer Cells

Influence of Interferon Alpha on Expression of Fas and Fas Ligand in Dendritic Cells from Patients with Chronic Myeloid Leukemia.

The biological effect of Fas Ligand transfected HepG2 cell

Cervical carcinoma cell apoptosis and the expression of Fas and Fas ligand in human